GRIT Bio Appoints Jie Jia, Ph.D., as Chief Operating Officer

GRIT Bio Appoints Jie Jia, Ph.D., as Chief Operating Officer

SHENZHEN, China, Jan. 3, 2025 /PRNewswire/ -- Shenzhen GRIT Biotechnology Co., Ltd., a leading company in cell therapy globally, today announced the appointment of Jie Jia, Ph.D., as Chief Operating Officer (COO), effective on the date of this press...

Juncell Therapeutics Opens State-of-the-Art Facility for TIL Production

Juncell Therapeutics Opens State-of-the-Art Facility for TIL Production

SHANGHAI, Dec. 18, 2024 /PRNewswire/ -- Shanghai Juncell Therapeutics Co., Ltd. (Juncell Therapeutics), a clinical-stage biotech focused on innovative IL-2-independent Tumor-Infiltrating Lymphocyte (TIL) therapies, announced the grand opening of its...

menu
menu